Contemporary Management and Prognosis in Japanese peripheral artery disease patients with endovascular treatment
Not Applicable
- Conditions
- Peripheral artery disease
- Registration Number
- JPRN-UMIN000015100
- Lead Sponsor
- Tokyo Medical University Ibaraki Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
1.patients with endovascular treatment for the aneurysm 2.inappro@riate patients determined from study director
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients Base: MACCE;Major Adverse Cardio-CerebroVascular Event(all cause death, myocardial infarction,stroke) MAE;Major Adverse Event(MACCE,unscheduled major amptation, acute limb ischemia, major limb reintervention) Limb base: MALE;Major Adverse Limb Event(unscheduled major amptation, unscheduled major limb reintervention, acute limb ischemia, unscheduled limb endovascular treatment)
- Secondary Outcome Measures
Name Time Method 1.safty in endovascular treatment 2.Procedure and lesion success 3.Puncture site complications by hemostasis device use 4.limb reintervention with restenosis 5.limb endovascular treatment with new lesion 6.stent thrombosis in lower limb 7.Bleeding event 8.Aortic event 9.event that requires regular hemodialysis 10.hospitalization with heart failure 11.new diagonosis of malignancy 12.change of limb sympton